Welcome to World ADC London

The 12th Annual World ADC London returns in-person in 2022 as Europe’s longest standing and definitive antibody-drug conjugate event; and it’s back bigger and better than before!

With the approvals of Zynlonta and Tivdak within the last 12 months there are now 11 commercially available ADCs on the market. Furthermore, recent Enhertu and Polivy data suggests that ADCs could be soon be used as earlier line treatments to improve patient outcomes sooner. Undoubtedly, the momentum and inspiration that ADCs and ADC developers are gathering means that it’s an incredibly exciting time for the entire community.

Covering all aspects of ADC development from discovery through to late stage manufacturing, now is the time to join the biggest community of thought leaders and experts within the ADC space in Europe. Through in-depth research with the industry, our four-day, four-streamed agenda has been created to address the most important challenges in bringing next generation of clinically impactful ADCs to the hands of patients.

Exploring novel linker-payloads, overcoming critical in vivo and translational difficulties, optimising dosage and patient selection within the clinic, streamlining process development and achieving pure and consistent drug substance in early and late clinical/commercial settings; wherever your interest and expertise lies, we have it covered!

You cannot afford to miss World ADC London 2022 as we bring you more speakers, content and networking opportunities than ever before!

About World ADC Series

The World ADC team ploughs its collective energy into sourcing the insights you need. We investigate the most challenging problems facing the industry; source the leading experts who have game-changing solutions; and distill this into accessible formats of information exchange – for you. From globally leading conferences, to webinars and industry reports, whatever the information you need, World ADC can offer you the insights you need to accelerate your ADC programs.

The value World ADC provides you is the power of insight and connections. Not artificial, and not short-lived. We nurture the right environments in which people can communicate problems and solutions; share novel data and forge networks across the industry that will make each of your endeavors more informed and more robust.

We share a common belief with the industry – that the potential of antibody drug conjugates is enormous. In the war against cancer, ADCs can be a game-changer and we know that the right insights and connections can sharpen the weapons that are in your arsenal.

Join us at the heart of the ADC community to improve your programs and be part of the mission to develop better antibody drug conjugate drugs.

HW2111101 22679 ΓÇô 12th World ADC London 2022 web Banner4

Other Events In The Series

Proud to Partner With